20-Week Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia
Clinical trial NCT01906489 · COMPLETED
Trial details
- NCT number
- NCT01906489
- Sponsor
- Akebia Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-23
- Primary completion
- 2014-09-03
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.